GE HealthCare Enters Material Definitive Agreement
Ticker: GEHC · Form: 8-K · Filed: 2024-12-12T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, financial-obligation
Related Tickers: GEHC
TL;DR
GE HealthCare just signed a big deal that's gonna cost 'em.
AI Summary
On December 11, 2024, GE HealthCare Technologies Inc. entered into a material definitive agreement, which also created a direct financial obligation for the registrant. The filing does not provide specific details on the agreement or the financial obligation.
Why It Matters
This filing indicates GE HealthCare has entered into a significant new agreement that will create a financial obligation, potentially impacting its financial structure and future operations.
Risk Assessment
Risk Level: medium — The creation of a material definitive agreement and a direct financial obligation suggests a significant event that could carry financial risks or opportunities not yet disclosed.
Key Players & Entities
- GE HealthCare Technologies Inc. (company) — Registrant
- December 11, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by GE HealthCare Technologies Inc.?
The filing states that GE HealthCare Technologies Inc. entered into a material definitive agreement on December 11, 2024, but does not specify its nature.
What is the direct financial obligation created by this agreement?
The filing indicates the creation of a direct financial obligation for GE HealthCare Technologies Inc. as a result of the agreement, but the specific details of this obligation are not provided.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 11, 2024.
What is the principal executive office address for GE HealthCare Technologies Inc.?
The principal executive offices of GE HealthCare Technologies Inc. are located at 500 W. Monroe Street, Chicago, IL 60661.
What is the SEC file number for GE HealthCare Technologies Inc.?
The SEC file number for GE HealthCare Technologies Inc. is 001-41528.
From the Filing
0001193125-24-277089.txt : 20241212 0001193125-24-277089.hdr.sgml : 20241212 20241212163015 ACCESSION NUMBER: 0001193125-24-277089 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241211 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241212 DATE AS OF CHANGE: 20241212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 241545274 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d916467d8k.htm 8-K 8-K false 0001932393 0001932393 2024-12-11 2024-12-11     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 11, 2024     GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 500 W. Monroe Street , Chicago , IL     60661 (Address of principal executive offices)     (Zip Code) (Registrant’s telephone number, including area code) (833) 735-1139   (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 1.01 Entry into a Material Definitive Agreement. On December 11, 2024, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “2024 364-Day Revolving Credit Agreement”) among the Company, Citibank, N.A., as administrative